Cargando…
Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications
Cancer stem cells (CSCs) are considered a subset of the bulk tumor responsible for initiating and maintaining the disease. Several surface cellular markers have been recently used to identify CSCs. Among those is CD133, which is expressed by hematopoietic progenitor cells as well as embryonic stem c...
Autores principales: | Kelly, Sarah E., Di Benedetto, Altomare, Greco, Adelaide, Howard, Candace M., Sollars, Vincent E., Primerano, Donald A., Valluri, Jagan V., Claudio, Pier Paolo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851647/ https://www.ncbi.nlm.nih.gov/pubmed/20386701 http://dx.doi.org/10.1371/journal.pone.0010035 |
Ejemplares similares
-
Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer()
por: Howard, Candace M., et al.
Publicado: (2020) -
Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series()
por: Ranjan, Tulika, et al.
Publicado: (2020) -
Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer
por: Howard, Candace M, et al.
Publicado: (2021) -
Targeting a Newly Established Spontaneous Feline Fibrosarcoma Cell Line by Gene Transfer
por: Nande, Rounak, et al.
Publicado: (2012) -
Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients’ healthcare costs
por: Ranjan, Tulika, et al.
Publicado: (2023)